Isolated deficiency of platelet procoagulant activity

The American Journal of Medicine

Volumn 67, Issue 2, 1979, Pages 206-213

  Weiss, Harvey J ^a   Vicic, William J ^a   Lages, Bruce A ^a   Rogers, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROCOAGULANT;

BLEEDING DISORDER; BLOOD AND HEMOPOIETIC SYSTEM; CASE REPORT; ETIOLOGY; MAJOR CLINICAL STUDY; THROMBOCYTOPATHY;

ADULT; BINDING SITES; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CASE REPORT; FACTOR V; FACTOR X; FEMALE; HEMOSTASIS; HUMAN; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET FACTOR 3; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018765862     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(79)90392-9     Document Type: Article

References (52)

1. Platelet physiology and abnormalities of platelet function
2. Platelet physiology and abnormalities of platelet function
3. Isolation and properties of the third clotting factor in blood-platelets
4. Purification and quantitative determination of platelet factor 3
5. Studies on the chemistry of blood coagulation. III. The chemical constituents of blood platelets and their role in blood clotting, with remarks on the activation of clotting by lipids
6. Platelet phosphatides: their separation, identification and clotting activity
7. Studies on human platelet granules and membranes
8. Platelet aggregation and the availability of platelet factor 3
9. Studies on platelet factor 3 availability
10. Platelet aggregation, adhesion and ADP release in thrombopathia (platelet factor 3 deficiency)—a comparison with Glanzmann's thrombasthenia and von Willebrand's disease
11. The significance of platelet coagulant activities in hemostasis and thrombosis
12. Platelet factor-3 availability and the platelet release reaction
13. The activation of stuart factor (factor X) by activated antihemophilic factor (activated factor VIII)
14. The mandatory role of lipid in the interaction of factors VIII and IX
15. Role of lipids in blood coagulation
16. The role of platelets in the contact phase of blood coagulation
17. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets, Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII
18. Platelets and the initiation of intrinsic clotting
19. Congenital and acquired qualitative platelet disorders
20. Thrombopathy
21. Qualitative platelet disorders: classification and pathogenesis
22. Abnormalities in platelet function due to defects in the release reaction
23. Hereditary thrombocytopathy: a familial bleeding disorder due to impaired platelet coagulant activity
24. Thrombocytopathia with abnormalities in platelet release reaction
25. Thrombocytopathia due to abnormalities in platelet release reaction—studies on six unrelated patients
26. The detection of platelet defects in patients with mild bleeding disorders—use of a quantitative assay for platelet factor 3
27. +
28. Metabolism and function of human platelets washed by albumin density gradient separation
29. Defects of factor VIII and platelet aggregation—use of ristocetin in diagnosing the von Willebrand syndrome
30. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis
31. Decreased adhesion of platelets to subendothelium in von Willebrand's disease
32. Platelet factor 4 in platelet disorders Storage location and the requirement of endogenous ADP for its release
33. Studies of platelet 5-hydroxytryptamine (serotonin) in patients with storage pool disease and albinism
34. Content and thrombin-induced release of acid hydrolases in gel filtered platelets from patients with storage pool disease
35. Mediterranean macrothrombocytopenia
36. Studies on the development of factor V suspensions of human platelets (abstract)
37. Behavior of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline
38. The phospholipid and fatty acid composition of platelets in patients with primary defects of platelet function
39. Comparison of the coagulant activities of platelets and phospholipids
40. A new approach to the thrombocytopathy A
41. Soybean phosphatides in prothrombin consumption and thromboplastin-generation tests: their use in recognizing thrombasthenic hemophilia
42. Studies of platelet function and proteins in three patients with Glanzmann's thrombasthenia
43. Availablility of platelet factor 3 and activation of factor XII in thrombasthenia
44. Hereditary giant platelet syndrome: Absence of collagen-induced coagulant activity and deficiency of factor XI binding to platelets
45. Recent advances in platelet lipid metabolism research
46. Relationship between factor V and activated factor X in the generation of prothrombinase
47. Interaction of coagulation factor Xa with human platelets
48. Properties of the factor Xa binding site on human platelets
49. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets
50. Platelet membrane glycoproteins in thrombasthenia. Bernard-Soulier syndrome and storage pool disease
51. Procoagulant activity of platelets in recalcified plasma